Safinamide Mesylate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Safinamide Mesylate
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

evonik-m-2025-09-08

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Safinamide Mesylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 12 USDMF, 1 JDMF, 6 EU WC, 6 KDMF, 6 NDC API, 23 Listed Suppliers, $ API Reference Price

33 API Suppliers
12 USDMF
1 JDMF
6 EU WC
6 KDMF
6 NDC API
23 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

32 FDF Dossiers, 14 FDA Orange Book, 12 Europe, 4 Australia, 2 South Africa

32 FDF Dossiers
14 FDA Orange Book
12 Europe
4 Australia
2 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 50MG BASE

TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 5 DKSH, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 2 DFE Pharma, 6 Gangwal Chemicals, 4 Ideal Cures, 10 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Vasa Pharmachem

1 SPI Pharma
5 DKSH
2 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 ACG Worldwide
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
10 Corel Pharma Chem
2 DFE Pharma
6 Gangwal Chemicals
4 Ideal Cures
10 Kerry
1 Keval Exports
3 Kima Chemical
6 Lonza Capsugel
8 Microlex e.U
2 Nitika Pharmaceutical Specialities
1 Novo Excipients
1 Pharmatrans-Sanaq
1 Pluviaendo
2 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
1 Qualicaps
9 Roquette
6 Seppic
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
8 Sigachi Industries
2 Silverline Chemicals
2 The Dow Chemical Company
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Coating Systems & Additives, 22 Fillers, Diluents & Binders, 14 Controlled & Modified Release, 12 Thickeners and Stabilizers, 11 Lubricants & Glidants, 9 Direct Compression, 7 Film Formers & Plasticizers, 7 Co-Processed Excipients, 7 Granulation, 5 Disintegrants & Superdisintegrants, 5 Empty Capsules, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Coloring Agents, 4 Rheology Modifiers, 4 Emulsifying Agents, 1 Solubilizers, 1 Topical

39 Coating Systems & Additives
22 Fillers, Diluents & Binders
14 Controlled & Modified Release
12 Thickeners and Stabilizers
11 Lubricants & Glidants
9 Direct Compression
7 Film Formers & Plasticizers
7 Co-Processed Excipients
7 Granulation
5 Disintegrants & Superdisintegrants
5 Empty Capsules
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
4 API Stability Enhancers
4 Taste Masking
4 Coloring Agents
4 Rheology Modifiers
4 Emulsifying Agents
1 Solubilizers
1 Topical

DIGITAL CONTENT

35 News #PharmaBuzz

35 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 10 Regulatory FDF Prices, 2 Annual Reports

2 US Medicaid Prescriptions
10 Regulatory FDF Prices
2 Annual Reports

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

6 US Patents, 2 Health Canada Patents

6 US Patents
2 Health Canada Patents

$ API Ref.Price (USD/KG) : 1,505 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Kirby Eades Gale Baker

filter Patent Reset all filters

2 All

01 22523188

filter Product Reset all filters

2 All

01 2SAFINAMIDE

filter Dosage Reset all filters

2 All

01 2TABLET

filter Exp Date Reset all filters

2 All

01 22024-04-08

Polpharma Safinamide Methanesulfonate

Product Main Page

01

Kirby Eades Gale Baker

SAFINAMIDE

ESCRS

Not Confirmed

Kirby Eades Gale Baker

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-08

Date Granted : 2012-09-25

Brand Name : ONSTRYV

Patent Number : 2523188

Filing Date : 2004-04-08

Strength per Unit : 50 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-04-08

Date Granted : 2012-09-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Kirby Eades Gale Baker

SAFINAMIDE

ESCRS

Not Confirmed

Kirby Eades Gale Baker

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-08

Date Granted : 2012-09-25

Brand Name : ONSTRYV

Patent Number : 2523188

Filing Date : 2004-04-08

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-04-08

Date Granted : 2012-09-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!